Precision medicine in advanced NENs: Molecular profiling and target actionability real world data

被引：0
|
作者：
Farinea, G. [1 ]
Anton-Pascual, B. [2 ]
Catoya, J. L. [2 ]
Modrego, A. [2 ]
La Salvia, A. [3 ]
Lens-Pardo, A. [4 ]
Carretero-Puche, C. [4 ]
Rubio-Cuesta, B. [4 ]
Lamas-Paz, A. [4 ]
Soldevilla, B. [4 ]
Garcia-Carbonero, R. [2 ]
机构：
[1] AOU Osped San Luigi, Turin, Italy
[2] Hosp 12 Octubre, Madrid, Spain
[3] Natl Inst Hlth ISS, Natl Ctr Drug Res & Evaluat, Rome, Italy
[4] Hosp 12 Octubre, Inst Invest Sanitaria, CNIO, Madrid, Spain
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2024年 / 36卷
关键词：
genomic profiling; escat; nen; precision medicine;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
F04
引用
收藏
页码：153 / 153
页数：1
相关论文
共 50 条
  • [1] Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data
    Boileve, Alice
    Faron, Matthieu
    Fodil-Cherif, Sarah
    Bayle, Arnaud
    Lamartina, Livia
    Planchard, David
    Tselikas, Lambros
    Kanaan, Christina
    Scoazec, Jean Yves
    Ducreux, Michel
    Italiano, Antoine
    Baudin, Eric
    Hadoux, Julien
    EUROPEAN JOURNAL OF CANCER, 2023, 186 : 122 - 132
  • [2] Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: The Gustave Roussy experience
    Boileve, A.
    Faron, M.
    Bayle, A.
    Mouren, A.
    Lamartina, L.
    Planchard, D.
    Roux, C.
    Scoazec, J. Y.
    Ducreux, M.
    Italiano, A.
    Baudin, E.
    Hadoux, J.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 102 - 102
  • [3] Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI
    Kieler, Markus
    Unseld, Matthias
    Bianconi, Daniela
    Waneck, Fredrik
    Mader, Robert
    Wrba, Fritz
    Fuereder, Thorsten
    Marosi, Christine
    Raderer, Markus
    Staber, Philipp
    Berger, Walter
    Sibilia, Maria
    Polterauer, Stephan
    Muellauer, Leonhard
    Preusser, Matthias
    Zielinski, Christoph C.
    Prager, Gerald W.
    ESMO OPEN, 2019, 4 (04)
  • [4] PRECISION MEDICINE IN BREAST CANCER MUST CONSIDER TARGET ACTIONABILITY
    不详
    CANCER DISCOVERY, 2022, 12 (11) : 2494 - 2494
  • [5] The importance of real-world data to precision medicine
    Kalra, Dipak
    PERSONALIZED MEDICINE, 2019, 16 (02) : 79 - 82
  • [6] Retrospective analysis of real-world data to evaluate actionability of a large molecular profiling panel in solid tumors (REALM study)
    Leroy, K.
    Valette, C. Audigier
    Galoin, S.
    Civet, A.
    Italiano, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S17 - S17
  • [7] Molecular Profiling and the Promise of Precision Medicine
    Marshall, John L.
    ONCOLOGY-NEW YORK, 2021, 35 (03): : 108 - 110
  • [8] Molecular profiling in precision medicine oncology
    Christophe Le Tourneau
    Edith Borcoman
    Maud Kamal
    Nature Medicine, 2019, 25 : 711 - 712
  • [9] Molecular profiling in precision medicine oncology
    Le Tourneau, Christophe
    Borcoman, Edith
    Kamal, Maud
    NATURE MEDICINE, 2019, 25 (05) : 711 - 712
  • [10] Initiative for Molecular Profiling and Advanced Cancer Therapy and challenges in the implementation of precision medicine
    Tsimberidou, Apostolia-Maria
    CURRENT PROBLEMS IN CANCER, 2017, 41 (03) : 176 - 181
12345